Palliative bipolar electrocoagulation treatment of malignant gastroesophageal strictures

Massimo Conio, Luigina Bonelli, Hugo Martines, Francesco Munizzi, Hugo Aste

Research output: Contribution to journalArticlepeer-review


Seventeen patients with non-resectable circumferential malignant strictures of the esophagus (n=13) or the gastroesophageal junction (n=4) were treated with a bipolar electrocoagulation tumor probe (BICAP). None had received prior radiotherapy or chemotherapy. The mean tumor length was 7.2 cm. After treatment swallowing was improved in 86.7% of the patients. The mean duration of response to the first treatment was 18 days. Three major complications (1 fatal hemorrhage, 2 tracheoesophageal fistulae) and two minor complications (chest pain) were observed. The overall actuarial survival rate after 13 months of follow-up was 20%. The BICAP tumor probe can be considered an efficacious and safe device in selected patients with long, circumferential esophageal cancers.

Original languageEnglish
Pages (from-to)164-167
Number of pages4
JournalSurgical Endoscopy and Other Interventional Techniques
Issue number3
Publication statusPublished - 1990


  • Bipolar electrocoagulation treatment
  • Malignant gastroesophageal strictures
  • Palliative therapy

ASJC Scopus subject areas

  • Surgery

Fingerprint Dive into the research topics of 'Palliative bipolar electrocoagulation treatment of malignant gastroesophageal strictures'. Together they form a unique fingerprint.

Cite this